Pacific Biosciences' Shares Plummet on Backlog Concerns

Concerns about a lighter-than-expected backlog of instrument orders and the funding environment led to a sharp decline in the firm's stock.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.